VA Medicinal Cannabis Research Act of 2026
Directs VA to study cannabis use among veterans with chronic pain or PTSD and conduct clinical trials if it can meet the requirements.
In the House Veterans' Affairs Committee since Oct. 1, 2026, 7 days after it was introduced. Most bills never leave committee.
- INTRODUCEDINTROOCT 1, 2026
- COMMITTEECOMM.IN COMMITTEE
- HOUSEHOUSE—
- SENATESENATE—
- LAWLAW—
What the bill would do, and why it matters
Cannabis may affect pain, PTSD symptoms, medication use, and other aspects of health. The bill would have VA study those effects among veterans with chronic pain or PTSD, then conduct clinical trials if VA says it can meet the requirements. It also sets rules for protecting participants and reporting the research.
- INTRODUCED ONLY This bill has been introduced and possibly referred to a committee, but it has not passed any vote. Most introduced bills never become law — they die in committee without a hearing.
- DATA NOTE No Congressional Research Service summary was available.
- Study veterans’ cannabis outcomes
VA would conduct an 18-month observational study of cannabis use and health outcomes among veterans enrolled in VA care who have chronic pain or PTSD. It would review VA health and benefits records, compare outcomes, and survey veterans who sought VA care for either condition during the five years before the survey.
- Begin clinical trials if VA is ready
If VA reports that it can meet the requirements for clinical trials, it would start a series of trials within 180 days of that report. The trials would examine cannabis for veterans with chronic pain or PTSD, including different forms of cannabis and plant varieties with different THC-to-CBD ratios.
- Protect participants and study data
The study and trials would include veterans whose demographics represent the U.S. veteran population. VA would preserve and register study data in a clinical-studies database, anonymize it so it cannot be traced to an individual, and ensure participation does not affect a veteran’s eligibility or entitlement to other benefits.
- Report on research and safety
VA would report to the House and Senate Veterans’ Affairs Committees on the initial study and on whether it can proceed to trials. During the five-year period beginning when the trials start, VA would report at least annually; it could end trials if it cannot meet clinical guidelines or determines they pose excessive risk.
The bill’s stated purpose is to study both positive and negative health outcomes linked to cannabis use among veterans with chronic pain or PTSD. The research would examine potential changes in medication and alcohol use, symptoms, quality of life, and other health outcomes.
The results could inform what VA knows about those outcomes and whether it can safely conduct clinical trials. The bill also directs VA to consider participant risk and allows it to end trials if it determines they pose excessive risk.
Written from the bill text.
The path it took, step by step
- IntroducedOCT 1, 2026HOUSEOCT 1, 2026By Rep. Correa with 4 original cosponsorsReferred to Veterans' Affairs
- SAME DAYNOWHouse committeeOCT 1, 2026VETERANS' AFFAIRS NOWOCT 1, 2026In committee for 7 daysNo hearing yet
- 7 DAYS SO FARPassed the House—HOUSE FLOOR—Not scheduled
- Senate committee—SENATE—
- Passed the Senate—SENATE FLOOR—Not scheduled
- Resolve differencesONLY IF NEEDEDBOTH CHAMBERSONLY IF NEEDEDSkipped if the other chamber passes the same text
- Signed into law—PRESIDENT—10 days to sign or veto
- OCT 12026OCT 1, 2026REFERREDHOUSEReferred to the House Committee on Veterans' Affairs.
- OCT 12026OCT 1, 2026INTRODUCEDHOUSEIntroduced in House
At day 7, this bill is already older than 3% of the laws passed this Congress were when they were signed.
Where your members stand on it
A coalition from 4 states
Plus the sponsor, a Democrat. The smaller side has 1 member.
Plus the sponsor, a Democrat. The smaller side has 1 member.
Rep. Correa’s record: sponsored 24 bills this Congress. 1 passed the House; 0 became law.
- Jack BergmanR-MI-1ORIGINAL
- Val T. HoyleD-OR-4ORIGINAL
- Seth MoultonD-MA-6ORIGINAL
- Dina TitusD-NV-1ORIGINAL
What readers think
Discussion
Get an alert when it changes stage, gets a floor vote in the House, or is signed into law.